Search Results
Feb 18, 2026, 16:05 ET BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
and operational excellence, along with the proactive pursuit of initiatives that expand our portfolio and enhance our long‑term outlook," said Thomas J. Appio, Chief Executive Officer, Bausch Health.
More news about: Bausch Health Companies Inc.
Feb 18, 2026, 15:41 ET La serie totalmente eléctrica de Toyota se amplía con el nuevo SUV bZ Woodland, robusto y potente
de 281 millasTracción total (AWD) con doble motorCable de carga de doble voltaje 120 V/240 V de serieAdaptadores de carga J1772 y CCS1 de serieDistancia al suelo de 8.4 pulgadasX-MODE® con Grip ControlPortaequipaje en el techoLlantas
More news about: Toyota Motor North America
Feb 18, 2026, 15:35 ET Dewberry Announces New CEO, David J. Mahoney, PE
firm, with a proven track record of client service to public- and private-sector clients within the built and natural environments, has appointed David J. Mahoney, PE, chief executive officer, effective April 1, 2026. Mahoney has also been appointed to Dewberry's board of directors. A driving force behind
More news about: Dewberry
Feb 18, 2026, 14:57 ET REGGAETÓN PIONEERS LUNY TUNES TO BE HONORED WITH THE BMI PRESIDENT'S AWARD AT THE 2026 BMI LATIN AWARDS
the sound of contemporary Latin music.In receiving the BMI Impact Award, Elena Rose joins Edgar Barrera, GloRilla, Ice Spice, Arlo Parks, RAYE, P2J, Tems and Tito Double P among others.ABOUT BMI:Celebrating over 80 years of service to songwriters, composers, music publishers
More news about: Broadcast Music, Inc. (BMI)
Feb 18, 2026, 14:30 ET Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA
https://pubmed.ncbi.nlm.nih.gov/34248971/3. Jordan SC, et al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med. 2017 Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. Erratum in: N Engl J Med. 2017 Oct 26;377(17):1700. doi: 10.1056/NEJMx170015.4. Winstedt L, et al. Complete Removal
More news about: Hansa Biopharma AB
Feb 18, 2026, 14:28 ET Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA
https://pubmed.ncbi.nlm.nih.gov/34248971/3. Jordan SC, et al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med. 2017 Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. Erratum in: N Engl J Med. 2017 Oct 26;377(17):1700. doi: 10.1056/NEJMx170015.4. Winstedt L, et al. Complete Removal
More news about: Hansa Biopharma AB
Feb 18, 2026, 12:27 ET TWELVE DIRECTORS SLATED FOR GRAINGER'S BOARD TO BE VOTED ON AT THE COMPANY'S ANNUAL MEETING ON APRIL 29, 2026
Meeting of Shareholders are: Rodney C. AdkinsGeorge S. DavisKatherine D. JasponChristopher J. KleinD.G. MacphersonCindy J. MillerNeil S. NovichBeatriz R. PerezE. Scott SantiSusan A. Slavik WilliamsLucas E.
More news about: W.W. Grainger, Inc.
Feb 18, 2026, 12:07 ET J.McLaughlin and Frances Valentine Join Forces for the First Time on Spring 2026 Shoe Capsule
thrilled to launch Frances Valentine for J. McLaughlin footwear. It's rare to find a business partnership that is truly rooted in friendship, and that spirit is at the heart of this collaboration. The shoes are colorful, joyful, and a perfect complement to J. McLaughlin's beautiful collection."Additional
More news about: J.McLaughlin
Feb 18, 2026, 11:00 ET Philadelphia Phillies Choose to Deploy NexGen Hyperbaric's Mobile Unit and Onsite Clinical Team to Spring Training for the First Time
to incorporate this therapy seamlessly, and the benefits our players experienced support utilizing it from spring training forward."Jonathan J. Rotella, President & CEO of NexGen Hyperbaric, noted that the Phillies' decision reflects the strength and maturity of the partnership."This
More news about: Philadelphia Phillies
Feb 18, 2026, 10:39 ET The EveryLife Foundation for Rare Diseases Marks 15th Annual Rare Disease Week on Capitol Hill
worked tirelessly over their lifetime and/or career to uplift the rare disease community and whose work has improved the rare disease ecosystem. Frank J. Sasinowski, MS, MPH, JD will be this year's recipient. Sasinowski has helped secure FDA approval for hundreds of new drugs and has been involved in more
More news about: EVERYLIFE FOUNDATION FOR RARE DISEASES
Feb 18, 2026, 10:15 ET InventHelp Inventor Develops Smart Gas Line Shut-Off Valve (LJD-545)
wanted to create a smart gas line shut-off valve to detect and control natural gas leaks," said an inventor, from Corona, N.Y., "so I invented the N. W. J. My design would immediately alert the owner of a serious gas detection event, which could provide added safety and peace of mind."
More news about: InventHelp
Feb 18, 2026, 10:00 ET Grant & Eisenhofer P.A. and Levi & Korsinsky, LLP Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Class Action for All Record and Beneficial Holders of Experience Investment Corp. Class A Common Stock Who Purchased, Acquired, or Held Such Securities at Any Time Between September 17, 2019 and May 3, 2021
www.EICStockholderSettlement.com Inquiries, other than requests for the Notice, should be made to Plaintiffs' Counsel:Michael J. Barry, Esq. Grant & Eisenhofer P.A. 123 Justison Street, 7th Floor Wilmington, DE 19801 Telephone:
More news about: Grant & Eisenhofer P.A. and Levi & Korsinsky, LLP
Feb 18, 2026, 09:03 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242. doi:10.3390/foods13081242 Liang N, Koh J, Kim BJ, et al. Structural and functional changes of bioactive proteins in donor human milk treated by vat-pasteurization, retort sterilization, ultra-high-temperature
More news about: Prolacta Bioscience
Feb 18, 2026, 09:00 ET Lectron NACS, CCS, and J1772 Adapters Achieve UL 2252 Certification
Standard), formally designated as SAE J3400, comprehensive validation testing and standards compliance are critical.UL 2252–Certified Lectron AdaptersJ1772 to NACS AC AdapterAllows Tesla and NACS-equipped vehicles to connect to J1772 Level 1 and Level 2 chargers
More news about: Lectron
Feb 18, 2026, 09:00 ET ADDF Awards Prestigious 2026 Melvin R. Goodes Prize to Alzheimer's Research Pioneer Randall J. Bateman, MD
YORK, Feb. 18, 2026 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine in St. Louis, will
More news about: Alzheimer's Drug Discovery Foundation
Feb 18, 2026, 08:52 ET Seattle Fire Foundation Appoints Erica Lane as First Executive Director
www.seattle.gov/fire.About the M.J. Murdock Charitable Trust Created by the will of Melvin J. (Jack) Murdock, the Trust provides grants to organizations across five Pacific Northwest states. Since 1975, it has awarded more than $1 billion in grants.
More news about: Seattle Fire Foundation
Feb 18, 2026, 08:50 ET Draper Achieves Sustained Recirculation of Immune Cells in a Microphysiological System (MPS)
high-throughput microphysiological system (MPS) to study immune cell-vascular tissue interactions, was co-authored by Draper's Tyler Gerhardson, Nerses J. Haroutunian, Ryan Dubay, Joseph N. Urban, Anthony Quinnert, Brett C. Isenberg, Samuel H. Kann, Halee Kim, Robert Gaibler, Hesham Azizgolshani, Elizabeth
More news about: Draper Laboratory
Feb 18, 2026, 08:00 ET Ionic Digital Announces January 2026 Mining and Operations Update
discontinuance of operations at the site in February 2026, as well as no contribution from Cedarvale.Fleet efficiency for the month was 29.7 J/TH, reflecting the continued optimization within a more concentrated operating footprint, with a total of 44,445 active miners utilized during January 2026.
More news about: Ionic Digital Inc.
Feb 18, 2026, 07:30 ET RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer
https://doi.org/10.1158/1078-0432.CCR-16-09514Ferris RL, Blumenschein G Jr, Fayette J, et al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. New England Journal of Medicine. 2016;375(19):1856-1867. doi:10.1056/NEJMoa16022525Harrington
More news about: Johnson & Johnson
Feb 18, 2026, 07:00 ET BNCCORP, INC. REPORTS FOURTH QUARTER NET INCOME OF $2.2 MILLION, OR $0.62 PER DILUTED SHARE
Commentary"Our results in 2025 reflect the strength of our core banking franchise and the disciplined execution of our relationship-driven strategy," said Daniel J. Collins, BNC's President and Chief Executive Officer. "For the full year, we delivered meaningful growth in net interest income, expanded our net interest
More news about: BNCCORP, INC.
Feb 18, 2026, 06:45 ET Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
studies comparing brodalumab with ustekinumab in psoriasis. N Engl J Med. 2015;373(14):1318-1328.5 Langley RG, Elewski BE, Lebwohl M, et al. Secukinumab in plaque psoriasis — results of two phase 3 trials. N Engl J Med. 2014;371(4):326-338.6 Griffiths CE,
More news about: Eli Lilly and Company
Feb 18, 2026, 01:44 ET Photocure ASA: Results for the fourth quarter of 2025
https://qcnl.tv/p/0MElVGJID9j2vJqcZ9_SbAThe presentation is scheduled to conclude at 14:45 CET.For further information, please contact:Dan
More news about: Photocure
Feb 18, 2026, 01:40 ET Photocure ASA: Results for the fourth quarter of 2025
https://qcnl.tv/p/0MElVGJID9j2vJqcZ9_SbAThe presentation is scheduled to conclude at 14:45 CET.For further information, please contact:Dan
More news about: Photocure
Feb 18, 2026, 00:30 ET Waiting for You in Spring
new year.https://www.facebook.com/share/v/16qzxVxG3j/?mibextid=wwXIfr https://www.facebook.com/share/v/1HzZsYiBCg/
More news about: Shaanxi International Communication Center
Feb 18, 2026, 00:30 ET Waiting for You in Spring
new year.https://www.facebook.com/share/v/16qzxVxG3j/?mibextid=wwXIfr https://www.facebook.com/share/v/1HzZsYiBCg/
More news about: Shaanxi International Communication Center